R

Redhill Biopharma Ltd
D

RDHL

6.47000
USD
0.05
(0.78%)
Market Closed
Volume
63
EPS
-1
Div Yield
-
P/E
-0
Market Cap
8,285,087
OverviewSignalsIdeasNews
Related Instruments
    AZN
    AZN
    0.950
    (1.47%)
    65.370 USD
    B
    BCRX
    0.18000
    (2.44%)
    7.57000 USD
    BNTX
    BNTX
    1.810
    (1.63%)
    113.050 USD
    GILD
    GILD
    1.460
    (1.60%)
    92.570 USD
    I
    INO
    -0.01000
    (-0.54%)
    1.83000 USD
    MRK
    MRK
    -1.390
    (-1.40%)
    98.150 USD
    MRNA
    MRNA
    -0.200
    (-0.51%)
    39.360 USD
    N
    NNVC
    0.02000
    (1.35%)
    1.50000 USD
    PFE
    PFE
    0.595
    (2.31%)
    26.360 USD
    REGN
    REGN
    -5.64
    (-0.80%)
    702.60 USD
    V
    VSTM
    -0.24500
    (-5.51%)
    4.20000 USD
    More
News

Title: Redhill Biopharma Ltd

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company alsocommercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.